Moderna Inc (MIL:1MRNA)
€ 38.165 -0.445 (-1.15%) Market Cap: 14.61 Bil Enterprise Value: 9.32 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 44/100

Moderna Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 05:35PM GMT
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Great. Thank you. Good afternoon, everyone. My name is Gena Wang. I'm a SMID-cap biotech analyst. It's my great pleasure to introduce our next presenting company, Moderna. With us, we have Paul Burton, Chief Medical Officer.

Questions & Answers

Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

So Paul, maybe before I ask specific questions, we just saw COVID has some recent change in the past few weeks. What is Moderna's perspective on these?

Paul Burton
Moderna, Inc. - Chief Medical Officer

Yes. Thank you, Gena. Good afternoon, everybody. It's great to be here. Look, we have talked in recent weeks on the last Q call that we felt we would see a period of stability in cases, case counts declining here, certainly in the Northern Hemisphere, as we go into spring and into summer, and then they may rebound.

I would say with the events that we've seen in China, throughout Europe, the resurgence now, resurgence of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot